Article Information
History
- September 5, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Deanna G. Brockman, M.S., C.G.C1,2,*,†,
- Christina A. Austin-Tse, Ph.D., FACMG1,3,5,*,
- Renée C. Pelletier, M.S., C.G.C1,2,
- Caroline Harley, B.S.1,
- Candace Patterson, B.S.2,
- Holly Head, M.S., C.G.C1,
- Courtney Elizabeth Leonard, B.S.1,2,
- Kimberly O’Brien, B.S.3,
- Lisa M. Mahanta, B.S.3,
- Matthew S. Lebo, Ph.D., FACMG3,
- Christine Y. Lu, Ph.D, M.Sc.6,
- Pradeep Natarajan, M.D., M.MSc.1,2,4,7,
- Amit V. Khera, M.D., M.S.1,2,
- Krishna G. Aragam, M.D., M.S.1,2,
- Sekar Kathiresan, M.D.1,2,
- Heidi L. Rehm, Ph.D. FACMG1,4 and
- Miriam Udler, M.D., Ph.D.1,2,4,8
- 1Center for Genomic Medicine, Massachusetts General Hospital, Boston, Massachusetts
- 2Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts
- 3Laboratory for Molecular Medicine, Partners Personalized Medicine, Cambridge, Massachusetts
- 4Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts
- 5Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts
- 6Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts
- 7Cardiovascular Research Center, Massachusetts General Hospital, Boston, Massachusetts
- 8Diabetes Unit, Massachusetts General Hospital, Boston, Massachusetts
- ↵* Corresponding author: Deanna Brockman, Center for Genomic Medicine, Massachusetts General Hospital, 185 Cambridge Street, Boston, MA 02114, Tel: 617-724-2725, Email: Deanna.brockman{at}mgh.harvard.edu
↵* Deanna Brockman and Dr. Christina Austin-Tse contributed equally
Posted September 05, 2020.
Prospective evaluation of genome sequencing versus standard-of-care as a first molecular diagnostic test
